Bridion 200 MG/2 ML vial 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DA8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,490
Award facts
- Contract value 100% obligated
- $17,489.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,489.73 delivery order to AmerisourceBergen Drug Corp for the supply of Bridion (sugammadex) 200 mg/2 mL vials on November 24, 2025, with a completion date of November 25, 2025. This non-set-aside, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems. The company was competitively selected for this delivery order, demonstrating its capability to meet federal pharmaceutical supply requirements.
This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply portfolio under its DLA Troop Support Medical SPE2DX vehicle, which enables the company to supply a broad range of medications, vaccines, medical supplies, and specialized healthcare commodities to support military healthcare programs globally. The supply of Bridion, a neuromuscular reversal agent used in anesthesia, reflects the company's role in delivering critical specialty medications to Defense Health Agency and other federal healthcare systems. The award is positioned within DLA's broader pharmaceutical procurement strategy, which is transitioning toward the Pharmaceutical Prime Vendor Global Program Generation V contracts designed to support multi-region distribution through multiple contractor arrangements.
Quick answers
Who was awarded contract SPE2DR26F9DA8?
SPE2DR26F9DA8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F9DA8 worth?
The government has obligated $17,490 on SPE2DR26F9DA8.
Is contract SPE2DR26F9DA8 an order under another contract?
Yes. SPE2DR26F9DA8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9DA8 competed?
The extent of competition for SPE2DR26F9DA8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award